IL33 and arthritic joint disease: Adoptive transfer of adequate ILC2s to arthritis models, in which the isolated cells were expanded in vitro through stimulation using cytokines such as IL-2, IL-7, IL-25, IL-33, and TSLP [77], mitigated experimental arthritis.